-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
-
Summary
-
NeuroSense Therapeutics Ltd. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2022 to Q4 2024.
- NeuroSense Therapeutics Ltd. Common Stock, Shares, Outstanding for the quarter ending December 31, 2024 was 23.2M shares, a 51% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)